Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.

Michael Hindle(Virginia Commonwealth University), Henry Chrystyn(21c Consultancy (United Kingdom)), Duncan Newton(University of Bradford)
Thorax
June 1, 1993
Cited by 109


Related Papers